22-Year-Old With Chronic Asthma Died After Inhaler Price Went From $66 to $539: Lawsuit
The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...
verywellhealth1d
Can You Outgrow Asthma?
The short answer is no, you cannot outgrow asthma, but your symptoms may be less severe. Learn when asthma goes into ...
‘Chose rent over his medicine’: Parents of 22-year-old who died from asthma attack sue pharmacy over inhaler price jump
The parents of a young Wisconsin man have sued Walgreens and pharmacy benefit manager OptumRx over their son’s death from an ...
Le Lézard2d
Kinaset Therapeutics Announces FDA Clearance of IND Application for frevecitinib (KN-002) in Asthma Treatment
Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory diseases, today announced that the United States Food and Drug ...
PharmiWeb3d
Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...